The serial hemostasis-related changes in patients with cerebral infarction

comparison between progressing and non-progressing stroke

Chao Hung Ho, Han Hwa Hu, Wen Jang Wong

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Serial determinations of beta-thromboglobulin (BTG), platelet factor 4 (PF4), fibrinopeptide A (FPA), anti-thrombin III (ATIII), protein C (PC), fibrin(ogen) degradation product (FDP), FDP D-dimer, activated partial thromboplastin time (APTT), prothrombin time (PT), and euglobulin lysis time (ELT) were performed in 18 patients with non-progressing stroke and 14 patients with progressing stroke in order to predict the development of progressing stroke. Increasing levels of BTG, PF4 and FDP with frequent fluctuation were noted in both kinds of stroke. Fluctuation of FPA levels was also noted but was less pronounced. PC levels were found to be slightly decreased with fluctuation but the mean was still in the lower normal limit. BTG, PF4 and PC all elevated at the time of deterioration of physical condition in patients with progressing stroke, whereas FPA had no definite change at that time. From out study, we conclude that both platelet activation and coagulation process do occur in both kinds of stroke. But the latter plays a minor role in the formation of thrombosis. The hemostasis change, especially concerning the thrombosis formation, probably plays a role in the development of progressing stroke, but we cannot predict their development even by the detections of the newly known molecular substances appearing in various steps of the hemostatic mechanism. Developtment of new tests for understanding the whole dynamic change of the thrombosis process is necessary for accurate prediction of the progressing stroke in the future.

Original languageEnglish
Pages (from-to)635-647
Number of pages13
JournalThrombosis Research
Volume56
Issue number5
DOIs
Publication statusPublished - Dec 1 1989
Externally publishedYes

Fingerprint

Cerebral Infarction
Hemostasis
Stroke
Fibrinopeptide A
beta-Thromboglobulin
Platelet Factor 4
Fibrin Fibrinogen Degradation Products
Protein C
Thrombosis
Fibrin Clot Lysis Time
Partial Thromboplastin Time
Prothrombin Time
Platelet Activation
Hemostatics
Thrombin

Keywords

  • Cerebral infarction
  • non-progressing stroke
  • progressing stroke
  • serial hemostasis-related changes

ASJC Scopus subject areas

  • Hematology

Cite this

The serial hemostasis-related changes in patients with cerebral infarction : comparison between progressing and non-progressing stroke. / Ho, Chao Hung; Hu, Han Hwa; Wong, Wen Jang.

In: Thrombosis Research, Vol. 56, No. 5, 01.12.1989, p. 635-647.

Research output: Contribution to journalArticle

@article{998165c5b6624e78897825adccd5b55a,
title = "The serial hemostasis-related changes in patients with cerebral infarction: comparison between progressing and non-progressing stroke",
abstract = "Serial determinations of beta-thromboglobulin (BTG), platelet factor 4 (PF4), fibrinopeptide A (FPA), anti-thrombin III (ATIII), protein C (PC), fibrin(ogen) degradation product (FDP), FDP D-dimer, activated partial thromboplastin time (APTT), prothrombin time (PT), and euglobulin lysis time (ELT) were performed in 18 patients with non-progressing stroke and 14 patients with progressing stroke in order to predict the development of progressing stroke. Increasing levels of BTG, PF4 and FDP with frequent fluctuation were noted in both kinds of stroke. Fluctuation of FPA levels was also noted but was less pronounced. PC levels were found to be slightly decreased with fluctuation but the mean was still in the lower normal limit. BTG, PF4 and PC all elevated at the time of deterioration of physical condition in patients with progressing stroke, whereas FPA had no definite change at that time. From out study, we conclude that both platelet activation and coagulation process do occur in both kinds of stroke. But the latter plays a minor role in the formation of thrombosis. The hemostasis change, especially concerning the thrombosis formation, probably plays a role in the development of progressing stroke, but we cannot predict their development even by the detections of the newly known molecular substances appearing in various steps of the hemostatic mechanism. Developtment of new tests for understanding the whole dynamic change of the thrombosis process is necessary for accurate prediction of the progressing stroke in the future.",
keywords = "Cerebral infarction, non-progressing stroke, progressing stroke, serial hemostasis-related changes",
author = "Ho, {Chao Hung} and Hu, {Han Hwa} and Wong, {Wen Jang}",
year = "1989",
month = "12",
day = "1",
doi = "10.1016/0049-3848(89)90271-5",
language = "English",
volume = "56",
pages = "635--647",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - The serial hemostasis-related changes in patients with cerebral infarction

T2 - comparison between progressing and non-progressing stroke

AU - Ho, Chao Hung

AU - Hu, Han Hwa

AU - Wong, Wen Jang

PY - 1989/12/1

Y1 - 1989/12/1

N2 - Serial determinations of beta-thromboglobulin (BTG), platelet factor 4 (PF4), fibrinopeptide A (FPA), anti-thrombin III (ATIII), protein C (PC), fibrin(ogen) degradation product (FDP), FDP D-dimer, activated partial thromboplastin time (APTT), prothrombin time (PT), and euglobulin lysis time (ELT) were performed in 18 patients with non-progressing stroke and 14 patients with progressing stroke in order to predict the development of progressing stroke. Increasing levels of BTG, PF4 and FDP with frequent fluctuation were noted in both kinds of stroke. Fluctuation of FPA levels was also noted but was less pronounced. PC levels were found to be slightly decreased with fluctuation but the mean was still in the lower normal limit. BTG, PF4 and PC all elevated at the time of deterioration of physical condition in patients with progressing stroke, whereas FPA had no definite change at that time. From out study, we conclude that both platelet activation and coagulation process do occur in both kinds of stroke. But the latter plays a minor role in the formation of thrombosis. The hemostasis change, especially concerning the thrombosis formation, probably plays a role in the development of progressing stroke, but we cannot predict their development even by the detections of the newly known molecular substances appearing in various steps of the hemostatic mechanism. Developtment of new tests for understanding the whole dynamic change of the thrombosis process is necessary for accurate prediction of the progressing stroke in the future.

AB - Serial determinations of beta-thromboglobulin (BTG), platelet factor 4 (PF4), fibrinopeptide A (FPA), anti-thrombin III (ATIII), protein C (PC), fibrin(ogen) degradation product (FDP), FDP D-dimer, activated partial thromboplastin time (APTT), prothrombin time (PT), and euglobulin lysis time (ELT) were performed in 18 patients with non-progressing stroke and 14 patients with progressing stroke in order to predict the development of progressing stroke. Increasing levels of BTG, PF4 and FDP with frequent fluctuation were noted in both kinds of stroke. Fluctuation of FPA levels was also noted but was less pronounced. PC levels were found to be slightly decreased with fluctuation but the mean was still in the lower normal limit. BTG, PF4 and PC all elevated at the time of deterioration of physical condition in patients with progressing stroke, whereas FPA had no definite change at that time. From out study, we conclude that both platelet activation and coagulation process do occur in both kinds of stroke. But the latter plays a minor role in the formation of thrombosis. The hemostasis change, especially concerning the thrombosis formation, probably plays a role in the development of progressing stroke, but we cannot predict their development even by the detections of the newly known molecular substances appearing in various steps of the hemostatic mechanism. Developtment of new tests for understanding the whole dynamic change of the thrombosis process is necessary for accurate prediction of the progressing stroke in the future.

KW - Cerebral infarction

KW - non-progressing stroke

KW - progressing stroke

KW - serial hemostasis-related changes

UR - http://www.scopus.com/inward/record.url?scp=0024825934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024825934&partnerID=8YFLogxK

U2 - 10.1016/0049-3848(89)90271-5

DO - 10.1016/0049-3848(89)90271-5

M3 - Article

VL - 56

SP - 635

EP - 647

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 5

ER -